HIV-exposed and uninfected (HEU) infants have a higher risk of death than HIV-unexposed and uninfected infants, mostly from infections. We hypothesized that maternal HIV infection, even when virally suppressed, affects placental immunology and expression of FcRn, a receptor that facilitates maternal-fetal transmission of antibodies.
We conducted an observational study of 234 pregnant women with and without HIV in Pune, India (PRACHITi). Participants were enrolled during 2nd trimester and followed until 1 year postpartum. A convenience sample of 42 women had placenta collected at delivery. FcRn expression was analyzed by Western blot (normalized by GADPH) and compared using Image J. Placental CD4+ and CD8+ T-cell abundance was assessed by immunofluorescent counting per high powered field (5 fields/slide). Placental expression of TGF?, IL-6, IL-10, and IL-12 was measured by mRNA array. Continuous data were tested for normality with outliers identified using Grubb’s test. The one?way analysis of variance with Tukey post hoc test and chi-square analysis were used to compare categorical variables.
Of 42 placentae, 38 were of sufficient quality to analyze. The median gestational age at delivery was 38.3 weeks (IQR: 37.5-39.1). Of 18 women with HIV, all were on combined antiretroviral therapy (cART) with a median CD4 of 455 cells/mm3 at entry and 429 cells/mm3 at delivery. Ten (55%) were virally suppressed (?100 copies/mL); of those who were detectable, the median viral load was 151 (IQR: 118.15–539334). Relative placental FcRn expression was lower in women with HIV compared to without (median 0.54 vs. 0.84, p=0.01)(Fig 1A) and was not associated with CD4 or viral load. Compared to women without HIV, those with HIV had no differences in placental CD4+ T-cells or cytokine expression but had a significantly higher abundance of placental CD8+ T-cells (Fig 1B). Placental CD8+ T-cell numbers were similar in women with and without viral suppression (Fig 1C).
We found that women with HIV, even when virally suppressed, have lower placental FcRn expression, which may result in lower transmission of maternal antibodies. Women with HIV also had increased placental abundance of CD8+ T-cells, which has been associated with placental inflammation and poor infant outcomes (e.g. preterm birth). Taken together, our data suggest that maternal HIV causes placental immune dysregulation that is not completely reversed by cART and may contribute to the poorer outcomes of HEU infants.